Refinement and verification of the physiologically based dosimetry description for acrylonitrile in rats

Toxicology and Applied Pharmacology

Volumn 140, Issue 2, 1996, Pages 422-435

  Kedderis, Gregory L ^a   Teo, Steven K O ^a,b   Batra, Renu ^a   Held, Sara D ^a   Gargas, Michael L ^a,c  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b IIT RESEARCH INSTITUTE   (United States)

^c ChemRisk A Div of McLaren/Hart   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXIRANECARBONITRILE; ACRYLONITRILE; GLUTATHIONE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BLOOD; BRAIN; COMPUTER SIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DRUG METABOLISM; DRUG TISSUE LEVEL; DRUG TOXICITY; GAS CHROMATOGRAPHY; INHALATION; LIVER; MALE; MODEL; NONHUMAN; ORAL DRUG ADMINISTRATION; POPULATION EXPOSURE; RAT; STOMACH;

ANIMALIA;

EID: 0030273120     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0239     Document Type: Article

References (41)

1. Andersen, M. E., Gargas, M. L., and Ramsey, J. C. (1984). Inhalation pharmacokinetics: Evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:inhaled air concentration ratios. Toxicol. Appl. Pharmacol. 73, 176-187.
2. Arms, A. D., and Travis, C. C. (1988). Reference physiological parameters in pharmacokinetic modeling. US EPA/600/6-88/004, Final Report, NTIS, PB88-196019.
3. Benz, F. W., Nerland, D. E., Pierce, W. M., and Babiuk, C. (1990). Acute acrylonitrile toxicity: Studies on the mechanism of the antidotal effect of D-and L-cysteine and their N-acetyl derivatives in the rat. Toxicol. Appl. Pharmacol. 102, 142-150.
4. Bigner, D. D., Bigner, S. H., Burger, P. C., Shelburne, J. D., and Friedman, H. S. (1986). Primary brain tumours in Fischer 344 rats chronically exposed to acrylonitrile in their drinking water. Food Chem. Toxicol. 24, 129-137.
5. Csanády, G. A., Mendrala, A. L., Nolan, R. J., and Filser, J. G. (1994). A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man. Arch. Toxicol. 68, 143-157.
6. Delp, M. D., Manning, R. O., Bruckner, J. V., and Armstrong, R. B. (1991). Distribution of cardiac output during diurnal changes of activity in rats. Am. J. Physiol. 261, H1487-H1493.
7. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 4, 678-687.
8. Filser, J. G., and Bolt, H. M. (1984). Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats. Arch. Toxicol. 55, 219-223.
9. Folbergrová, J., Rehncrona, S., and Siesjö, B. K. (1979). Oxidized and reduced glutathione in the rat brain under normoxic and hypoxic conditions. J. Neurochem. 32, 1621-1627.
10. Frederick, C. B., Potter, D. W., Chang-Mateu, M. I., and Andersen, M. E. (1992). A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. Toxicol. Appl. Pharmacol. 114, 246-260.
11. Friedman, M., Cavins, J. F., and Wall, J. S. (1965). Relative nucleophilic reactivities of amino groups and mercaptide ions in addition reactions with α,β-unsaturated compounds. J. Am. Chem. Soc. 87, 3672-3682.
12. Gargas, M. L., Clewell, H. J., III, and Andersen, M. E. (1986). Metabolism of inhaled dihalomethanes in vivo: Differentiation of kinetic constants for two independent pathways. Toxicol. Appl. Pharmacol. 82, 211-223.
13. Gargas, M. L., Andersen, M. E., Teo, S. K. O., Batra, R., Fennell, T. R., and Kedderis, G. L. (1995). A physiologically-based dosimetry description of acrylonitrile and cyanoethylene oxide in the rat. Toxicol. Appl. Pharmacol. 134, 185-194.
14. Ghanayem, B. I., Boor, P. J., and Ahmed, A. E. (1985). Acrylonitrile-induced gastric mucosal necrosis: Role of gastric glutathione. J. Pharmacol. Exp. Ther. 232, 570-577.
15. Guengerich, F. P., Geiger, L. E., Hogy, L. L., and Wright, P. L. (1981). In vitro metabolism of acrylonitrile to 2-cyanoethylene oxide, reaction with glutathione and irreversible binding to proteins and nucleic acids. Cancer Res. 41, 4925-4933.
16. Hashimoto, K., and Aldridge, W. N. (1970). Biochemical studies on acrylamide, a neurotoxic agent. Biochem. Pharmacol. 19, 2591-2604.
17. Held, S. D., Gargas, M. L., and Kedderis, G. L. (1994). Kinetics of chloroform biotransformation determined in freshly isolated male and female rodent hepatocytes. ISSX Proc. 6, 168.
18. Hogy, L. L., and Guengerich, F. P. (1986). In vivo interaction of acrylonitrile and 2-cyanoethylene oxide in rats. Cancer Res. 46, 3932-3938.
19. Johanson, G., and Filser, J. G. (1993). A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation. Arch. Toxicol. 93, 151-163.
20. Kedderis, G. L., and Batra, R. (1993). Species differences in the hydrolysis of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile. Carcinogenesis 14, 685-689.
21. Kedderis, G. L., Batra, R., Held, S. D., Loos, M. A., and Teo, S. K. O. (1993a). Rodent tissue distribution of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile. Toxicol. Lett. 69, 25-30.
22. Kedderis, G. L., Batra, R., and Koop, D. R. (1993b). Epoxidation of acrylonitrile by rat and human cytochromes P450. Chem. Res. Toxicol. 6, 866-871.
23. Kedderis, G. L., Carfagna, M. A., Held, S. D., Batra, R., Murphy, J. E., and Gargas, M. L. (1993c). Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. Toxicol. Appl. Pharmacol. 123, 274-282.
24. Kedderis, G. L., Held, S. D., and Gargas, M. L. (1993d). Prediction of chemical pharmacokinetics in vivo using freshly isolated hepatocytes in vitro. ISSX Proc. 4, 61.
25. Kedderis, G. L., Sumner, S. C. J., Held, S. D., Batra, R., Turner, M. J., Jr., Roberts, A. E., and Fennell, T. R. (1993e). Dose-dependent urinary excretion of acrylonitrile metabolites by rats and mice. Toxicol. Appl. Pharmacol. 120, 288-297.
26. Kedderis, G. L., Held, S. D., and Batra, R. (1995). Kinetics of acrylonitrile biotransformation by isolated rat hepatocytes. Toxicologist 15, 283-284.
27. Leach, L. J. (1963). A laboratory test chamber for studying airborne materials. AEC Research and Development Report UR-629, pp. 1-12.
28. Maltoni, C., Ciliberti, A., Cotti, G., and Perino, G. (1987). Experimental Research on Acrylonitrile Carcinogenesis. Princeton Scientific Publication Co., Princeton, NJ.
29. Osterman-Golkar, S. M., MacNeela, J. P., Turner, M. J., Walker, V. E., Swenberg, J. A., Sumner, S. J., Youtsey, N., and Fennell, T. R. (1994). Monitoring exposure to acrylonitrile using adducts with N-terminal valine in hemoglobin. Carcinogenesis 15, 2701-2707.
30. Peter, H., Schwarz, M., Mathiasch, B., Appel, K. E., and Bolt, H. M. (1983). A note on synthesis and reactivity towards DNA of glycidonitrile, the epoxide of acrylonitrile. Carcinogenesis 4, 235-237.
31. Pilon, D., Roberts, A. E., and Rickert, D. E. (1988). Effect of glutathione depletion on the irreversible association of acrylonitrile with tissue macromolecules after oral administration to rats. Toxicol. Appl. Pharmacol. 95, 311-320.
32. Potter, D. W., and Tran, T.-B. (1993). Apparent rates of glutathione turnover in rat tissues. Toxicol. Appl. Pharmacol. 120, 186-192.
33. Ramsey, J. C., and Andersen, M. E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene monomer in rats and humans. Toxicol. Appl. Pharmacol. 73, 159-175.
34. Recio, L., and Skopek, T. R. (1988). Mutagenicity of acrylonitrile and its metabolite 2-cyanoethylene oxide in human lymphoblasts in vitro. Mutat. Res. 206, 297-305.
35. Roberts, A. E., Lacy, S. A., Pilon, D., Turner, M. J., Jr., and Rickert, D. E. (1989). Metabolism of acrylonitrile to 2-cyanoethylene oxide in F-344 rat liver microsomes, lung microsomes, and lung cells. Drug Metab. Dispos. 17, 481-486.
36. Stewart, P. A., Triolo, H., Zey, J., White, D., Herrick, R. F., Hormung, R., Dosemeci, M., and Pottern, L. M. (1995). Exposure assessment for a study of workers exposed to acrylonitrile. II. A computerized exposure assessment program. Appl. Occup. Environ. Hyg. 10, 698-706.
37. Teo, S. K. O., Kedderis, G. L., and Gargas, M. L. (1994). Determination of tissue partition coefficients for volatile tissue-reactive chemicals: Acrylonitrile and its metabolite 2-cyanoethylene oxide. Toxicol. Appl. Pharmacol. 128, 92-96.
38. U.S. Environmental Protection Agency (EPA) (1992). National emission standards for hazardous air pollutants for source categories; organic hazardous air pollutants from the synthetic organic chemical manufacturing industry and seven other processes. Fed. Regist. 57, 62,608-62,808.
39. Ward, C. E., and Starr, T. B. (1993). Comparison of cancer risks projected from animal bioassays to epidemiologic studies of acrylonitrile-exposed workers. Regul. Toxicol. Pharmacol. 18, 214-232.
40. Watanabe, P. G., Hefner, R. E., Jr., and Gehring, P. J. (1976). Vinyl chloride-induced depression of hepatic non-protein sulfhydryl content and effects on bromosulphalein (BSP) clearance in rats. Toxicology 6, 1-8.
41. West, J. B., and Wagner, P. D. (1991). Ventilation-perfusion relationships. In The Lung: Scientific Foundations (R. G. Crystal and J. B. West, Eds.), Vol. 2, pp. 1289-1305. Raven Press, New York.